Horizon 2020, Innovative Medicines Initiative (IMI) Joint Programing is launching two new calls

19/07/2017

Horizon 2020, Innovative Medicines Initiative (IMI) Joint Programing is launching two new calls

With topics on:

Alzheimer’s disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results.

 

 

The Innovative Medicines Initiative (IMI) is launching two new calls for proposals with topics on Alzheimer’s disease, big data, vaccines, autoimmune disease, the blood-brain barrier, drug development, and the exploitation of IMI project results. The total budget for the two Calls stands at just over EUR 130 million. Around half of this comes from the European Commission’s Horizon 2020 programme. The other half comes from EFPIA companies as well as IMI Associated Partners.

A webinar on Call 11 will be held 26 July at 14.30 (CET). Webinars for Call 12 have already taken place; presentations and recordings can be downloaded from the IMI website.

 

IMI Call 11 web: http://www.iserd.org.il/?CategoryID=174&ArticleID=583

 

IMI Call 12 web: http://www.iserd.org.il/?CategoryID=174&ArticleID=584

 

IMI Webinars: http://www.imi.europa.eu/events/2017/06/27/webinars-imi2-–-calls-11-12

 

For more information:

Mrs. Ayala Karniol, Director Health and IMI ,

ayala@iserd.org.il, 03-5118119

 

Jump to page content